Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Flachenecker

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 21, 2007
Costs and quality of life of multiple sclerosis in GermanyGisela Kobelt, Jenny Berg, Peter Lindgren, et al.
Clinical Rehabilitation|April 14, 2016
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded studyS Köpke, J Kasper, P Flachenecker, et al.
Neuroscience Letters|October 29, 2002
Norepinephrine transporter gene (NET) variants in patients with panic disorderP G Sand, T Mori, C Godau, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2007
Validation of the Multiple Sclerosis International Quality of Life questionnaireMc Simeoni, P Auquier, O Fernandez, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MSM Pugliatti, D Eskic, T Mikolcić, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis registries in Europe - An updated mapping surveyA Glaser, A Stahmann, T Meissner, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 21, 2007
Costs and quality of life of multiple sclerosis in GermanyGisela Kobelt, Jenny Berg, Peter Lindgren, et al.
Clinical Rehabilitation|April 14, 2016
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): a controlled rater-blinded studyS Köpke, J Kasper, P Flachenecker, et al.
Neuroscience Letters|October 29, 2002
Norepinephrine transporter gene (NET) variants in patients with panic disorderP G Sand, T Mori, C Godau, et al.
Der Nervenarzt|April 5, 2005
[MS registry in Germany--design and first results of the pilot phase]P Flachenecker, U K Zettl, U Götze, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2007
Validation of the Multiple Sclerosis International Quality of Life questionnaireMc Simeoni, P Auquier, O Fernandez, et al.
Acta Neurologica Scandinavica. Supplementum|January 3, 2013
Assess, compare and enhance the status of Persons with Multiple Sclerosis (MS) in Europe: a European Register for MSM Pugliatti, D Eskic, T Mikolcić, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Der Nervenarzt|March 2, 2016
[Monitoring of blood parameters under course-modified MS therapy : Substance-specific relevance and current recommendations for action]L Klotz, A Berthele, W Brück, et al.
Multiple Sclerosis and Related Disorders|November 2, 2018
Multiple sclerosis registries in Europe - An updated mapping surveyA Glaser, A Stahmann, T Meissner, et al.
Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.
Pageof 5